HCA Healthcare (NYSE:HCA) Releases FY 2025 Earnings Guidance

HCA Healthcare (NYSE:HCA - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 24.050-25.850 for the period, compared to the consensus estimate of 24.960. The company issued revenue guidance of $72.8 billion-$75.8 billion, compared to the consensus revenue estimate of $74.6 billion.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCA. StockNews.com upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Truist Financial dropped their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $381.13.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $3.29 during midday trading on Wednesday, hitting $343.87. 505,670 shares of the company's stock were exchanged, compared to its average volume of 1,392,661. HCA Healthcare has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a market cap of $84.66 billion, a P/E ratio of 15.65, a PEG ratio of 1.10 and a beta of 1.48. The stock's 50 day moving average price is $330.44 and its 200-day moving average price is $331.39. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the previous year, the company earned $5.36 earnings per share. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in HCA Healthcare stock. Brighton Jones LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,402 shares of the company's stock, valued at approximately $1,021,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.